Skip to main content
Clinical Trials/NCT05709210
NCT05709210
Recruiting
N/A

Pilot Study on the Feasibility of Using Smartphone Data as a Diagnostic Marker for Alzheimer's Disease

Poitiers University Hospital1 site in 1 country90 target enrollmentJuly 20, 2023

Overview

Phase
N/A
Intervention
Recording of smartphone usage data
Conditions
Alzheimer Disease
Sponsor
Poitiers University Hospital
Enrollment
90
Locations
1
Primary Endpoint
Comparison of a mathematical combination
Status
Recruiting
Last Updated
last month

Overview

Brief Summary

This study will compare smartphone usage data between three groups of patients diagnosed with either a memory complaint, mild cognitive decline, or Alzheimer's disease.

Detailed Description

Alzheimer's disease (AD) is the leading cause of dementia in the world. The first cognitive function affected is memory and then other cognitive systems are affected leading to a progressive loss of autonomy of the patient. Currently, the diagnosis of AD is made at too late a stage. Patients with memory complaints or mild cognitive decline (MCI) are particularly at risk of developing AD. However, there is no clinical or paraclinical evidence to predict precisely this risk of progression to AD. Investigator's hypothesis is that there is an association between the evolution of smartphone use and the conversion of cognitive status to AD. The purpose of this pilot study is to identify existing differences between smartphone use data of patients with a memory complaint or of patients MCI or with an AD. It is a study of 90 patients (30 patients with memory complaint, 30 with MCI and 30 with AD) with a collection of smartphone usage data during three months.

Registry
clinicaltrials.gov
Start Date
July 20, 2023
End Date
October 20, 2026
Last Updated
last month
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient consulting in routine care in one of the CMRR
  • No sensory impairment that may compromise smartphone use

Exclusion Criteria

  • Inability to perform MMSE or MMSE \< 20 ;
  • Other neurodegenerative condition (Parkinson's disease, Lewy body disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis)
  • Severe anxiety or depressive disorder HADS score ≥ 17
  • Terminal phase of a severe disease
  • Evidence of a lesion on MRI that may be involved in cognitive impairment

Arms & Interventions

Alzheimer's Disease

Intervention: Recording of smartphone usage data

Memory complaint

Intervention: Recording of smartphone usage data

Mild cognitive decline

Intervention: Recording of smartphone usage data

Outcomes

Primary Outcomes

Comparison of a mathematical combination

Time Frame: Up to three months

The comparison of a mathematical combination of the different parameters collected during the three months of smartphone data recording

Study Sites (1)

Loading locations...

Similar Trials